Biologics Blogs

Inaugural Nona Innovation Day

On November 28th, Nona Biosciences hosted its inaugural Nona Innovation Day event in Boston, USA, under the theme “Harnessing Advanced Technologies for Therapeutic Breakthroughs.” The event attracted nearly a hundred attendees from industry, renowned research institutions, and investment firms. The venue was packed, with enthusiastic participants and a vibrant atmosphere. Several authoritative experts shared valuable insights at the event, providing attendees with a glimpse into the forefront of industry innovation.

Nona Innovation Day also featured a cocktail reception and an exclusive dinner, providing a platform for networking and communication among the attendees. As the host of the event, Dr. Jinsong Wang, Chairman of Nona Biosciences, extended a warm welcome to all participants in his opening speech. He systematically introduced Nona Biosciences’ globally leading technological platform advantages, past achievements, and future prospects. Dr. Wang expressed Nona Biosciences’ commitment to staying at the forefront of empowering global biomedical innovation and dedicated efforts to drive the development of next-generation antibody drugs worldwide.

In the subsequent keynote session, Dr. Eric Smith, Professor at Harvard Medical School and Head of Translational Science at Dana-Farber Cancer Institute, and Dr. Tatiana Novobrantseva, Co-founder of Verseau Therapeutics and former Chief Scientific Officer at Moderna, shared application cases of CAR-T cell therapy and new strategies in cancer treatment. Following this, Dr. Steve Arkinstall, Chief Scientific Advisor at Nona Biosciences, moderated a panel discussion on “Key Technologies Driving Next-Generation Therapeutic Innovation.”

During the event, the highlight was the presentation of the “Special Contribution Award.” Dr. Jinsong Wang, on behalf of Nona Biosciences, presented the trophy to Dr. Frank Grosveld, the inventor of Harbour Mice® and Professor of Cell Biology at Erasmus University in Rotterdam. This award recognized Dr. Grosveld’s long-term support and outstanding contributions to Nona Biosciences.

In conclusion, Dr. Jinsong Wang expressed gratitude for the unique insights and viewpoints shared by the attendees. He emphasized that advanced technological innovation remains the constant theme in the global biopharmaceutical industry’s development. Nona Biosciences is committed to continuing to lead in innovation, using top-notch technology and unwavering passion to support partners in realizing their research dreams. The goal is to accelerate technological progress for the benefit of patients worldwide.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Our Team

Click Here
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound